Sirio Pharma Co (300791.SZ) Stock Price
Sirio Pharma Co Price
Revenue has compounded at 17.0% per year over the past 13 years to 4.26 B CNY. Earnings per share have grown at 8.9% per year over the last 13 years. Sirio Pharma Co's net margin stands at 3.2%, down from 9.8% several years earlier. Sirio Pharma Co currently offers a dividend yield of about 2.98%. The payout ratio is around 112% of earnings. The dividend has grown at 44.7% per year over the past 5 years. Analysts set a median price target of 31.11 CNY, implying 85.3% above the current price. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus.
Sirio Pharma Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Sirio Pharma Co business model & stock analysis
Frequently asked questions about Sirio Pharma Co
Analysts currently set an average price target of 31.11 CNY for the Sirio Pharma Co stock (median: 31.11 CNY), implying +89.7 % versus the latest price. The consensus is based on 8 analyst ratings.
8 analysts currently rate the Sirio Pharma Co stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Sirio Pharma Co to generate revenue of 4.24 B CNY and earnings per share of 1.01 CNY.
Converted at the current exchange rate, the Sirio Pharma Co share trades at 2.28 EUR (16.79 CNY).
The Sirio Pharma Co share (300791.SZ) is listed on 1 stock exchanges, including: Shenzhen (300791.SZ).
The expected revenue of Sirio Pharma Co is 4.24 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Sirio Pharma Co is 307.21 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Sirio Pharma Co is currently 16.69. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sirio Pharma Co stock.
The price-to-sales ratio (P/S) of Sirio Pharma Co is currently 1.21. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sirio Pharma Co stock.
The Eulerpool Quality Score for Sirio Pharma Co is 7/10.
The ISIN of Sirio Pharma Co is CNE100003NB0. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Sirio Pharma Co is 300791.SZ. The ticker symbol is used to trade Sirio Pharma Co shares on the stock exchange.
Sirio Pharma Co stock
Sirio Pharma Co Peer Group
Sirio Pharma Co Ticker
Sirio Pharma Co FIGI
All fundamentals and in-depth analysis of Sirio Pharma Co
Our stock analysis for Sirio Pharma Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sirio Pharma Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.